Navigation Links
Aeon Bioscience Continues Development of Drug Eluting Stents
Date:10/10/2007

BIRMINGHAM, Ala., Oct. 10 /PRNewswire-USNewswire/ -- Aeon Bioscience, Inc. today announced the recent acquisition of one of its key collaborators, Brookwood Pharmaceuticals, Inc. by SurModics, Inc., a major development in its quest to develop improvements in drug-eluting stent technology for the treatment of cardiovascular disease.

Aeon Bioscience was formed as a collaborative enterprise between Brookwood Pharmaceuticals, Inc. and Targeted Technology Ventures, LLC. Subsequent to announcing the collaboration on May 7, 2007, Brookwood was acquired on August 1, 2007 by SurModics, Inc., a leading provider of surface modification and drug delivery technologies to the healthcare industry. As a result of this acquisition, Aeon expects to benefit from SurModics' experience in developing drug delivery technologies for drug eluting stents.

Christopher E. Banas, Principal of Targeted Technology Ventures and CEO of Aeon Bioscience, said "The combined strengths of Brookwood and TTV have supplied Aeon with superior experience and talent in the use of biodegradable materials, drug delivery, vascular stent engineering, clinical testing, and the regulatory process. The addition of the SurModics team facilitates our ability to advance our technology to an even higher level, and at an accelerated pace, as we work to achieve our objective of developing a solution to the safety issues currently experienced with drug eluting stents." Dr. Paul Castella, Principal of TTV and co-founder of Aeon agrees, "We have an exceptional operating team, a renowned advisory board of international leaders in the field, and now a prominent set of added capabilities."

Dr. Arthur J. Tipton, Ph.D., President of Brookwood Pharmaceuticals, added "We remain excited about the opportunity presented by the Aeon technology. This collaboration will substantially benefit from the vast experience and expertise that the SurModics organization has accumulated in the cardiovascular market." '/>"/>

SOURCE Aeon Bioscience
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. OxyContin Abuse Continues To Rise
2. Alzheimer’s Continues to Ris
3. Uttar Pradesh Encephalitis toll continues to rise - Over 600 dead
4. Human Brain Continues To Evolve And Grow
5. War Against Cancer Continues
6. Botswana Continues Its Fight Against AIDS
7. US Continues Its War On Diabetes
8. Polio Continues To Haunt India
9. Reservation boycott by Medical student fraternity continues in Bangalore
10. Patients Left Helpless As Mumbai Doctors Strike Continues
11. Health Services Came To A Halt As Mumbai Doctors Strike Continues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... New York, New York (PRWEB) August 27, 2014 ... to be filed in U.S. courts on behalf of ... due to uterine morcellation, Bernstein Liebhard LLP reports. According ... was filed on August 18th in the U.S. District ... a hysterectomy patient who claims the use of a ...
(Date:8/27/2014)... TX (PRWEB) August 27, 2014 Picture, if ... not Holmes and Watson but more of a Mr. Inside, ... Davis, in terms of personalities and world view. This Mr. ... University of Texas at Austin, and Mr. Outside was an ... family physician, his new girlfriend, and a gaggle of teenagers ...
(Date:8/27/2014)... When Jagger was 20 years old and at ... that he credits as one of the most memorable phone ... she could set him up with a summer job; one ... that job, and he has now spent the past 22 ... he also worked in school boards, employment programs and youth ...
(Date:8/27/2014)... Abington, PA (PRWEB) August 27, 2014 ... Lower Gwynedd, PA on Monday, September 8, 2014. This ... outpatient campus that features three primary care practices and ... outpatient facility is a very exciting endeavor for Abington ... Merlis, president and CEO, Abington Health. “Establishing a location ...
(Date:8/27/2014)... Amy Norton HealthDay Reporter ... take part in clinical trials of new heart disease treatments ... a new study confirms. Experts said the findings, which ... Medical Association , aren,t surprising -- but they are troubling. ... a more select patient population that is not fully representative ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3
... for ... health plans, WOONSOCKET, R.I., June ... Health Insurance Plans,(AHIP) Institute 2008 to be held June 18-20, 2008 in ... Consumer,Experience" will discuss ways in which health plans can take a proactive,approach ...
... Cardo Medical,LLC, a company engaged in the ... Bulletin Board: CKST), a publicly-traded,company with no active ... Cardo Medical will become a wholly owned subsidiary ... be renamed,Cardo Medical, Inc., and will be headquartered ...
... League Baseball(TM) to raise awareness of, Benign Prostatic Hyperplasia (BPH), ... ... N.J., June 19 Hall of Fame third,baseman and Philadelphia Phillies legend ... Game Plan Starts with U:,Catch the Whole Game campaign, a program in ...
... Calif., and PHILADELPHIA, June 19 /PRNewswire-FirstCall/,-- Cord ... the umbilical cord,blood stem cell preservation company ... life saving potential of stem cells to ... joined New York,and California in enacting legislation ...
... study of identical twins has found that physical inactivity ... which help the cells produce energy. The findings suggest ... in people who are obese. Insulin resistance increases the ... study, "Acquired obesity and poor physical fitness impair expression ...
... Lab,Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma" or ... public offering. The offering,consisted of 130,869,566 series B ... was placed with Mexican investors., (Logo: ... 23.1% of the total offering size is,being sold ...
Cached Medicine News:Health News:CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008 2Health News:CVS Caremark to Present Insights on Redefining the Consumer Health Care Experience at AHIP Institute 2008 3Health News:clickNsettle.com, Inc. and Cardo Medical, LLC Announce Merger Agreement 2Health News:clickNsettle.com, Inc. and Cardo Medical, LLC Announce Merger Agreement 3Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 2Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 3Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 4Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 5Health News:Cord Blood America Says Pennsylvania Joins New York and California in Informing Parents of the Advantages of Umbilical Cord Blood Storage 2Health News:Lifestyle can alter gene activity, lead to insulin resistance 2Health News:Lifestyle can alter gene activity, lead to insulin resistance 3Health News:Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange 2
(Date:8/27/2014)... MISSISSAUGA, ON , Aug. 27, 2014 /CNW/ - Covalon ... medical technologies company, announces the following financial results for its ... months ended June 30, 2014: , Revenue of ... prior year , Net loss for the quarter of ... period of the prior year For the ...
(Date:8/27/2014)... SAN DIEGO , Aug. 27, 2014 Ambit ... discovery and development of drugs targeting unmet needs in oncology, ... the Baird 2014 Health Care Conference to be held at ... City on September 3-4, 2014. ... the Company and its lead drug candidate, quizartinib, at 1:10 ...
(Date:8/27/2014)... PASADENA, Calif. , Aug. 27, 2014  After ... Compensation and Personal Injury billing solution for medical ... extremely positive response toward the new software. ... Development Sandy Thompson . "The sheer number of ... how true the need was for these types of ...
Breaking Medicine Technology:Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
... July 20, 2011 The National Operating Committee on ... Disease Control and Prevention (CDC) are teaming up to ... designed specifically to provide parents with the facts about ... high school athlete concussions. The partnership, made possible by ...
... Minimally Invasive Devices, Inc. , (MID) has ... ™ laparoscopic visualization system.  This certification is mandatory for ...   The FloShield system provides for an ... from the insufflator to defog and deflect debris from ...
Cached Medicine Technology:NOCSAE, CDC Team Up to Give "Heads Up to Parents" About Concussions in Youth Sports 2NOCSAE, CDC Team Up to Give "Heads Up to Parents" About Concussions in Youth Sports 3NOCSAE, CDC Team Up to Give "Heads Up to Parents" About Concussions in Youth Sports 4Minimally Invasive Devices, Inc. Awarded CE Mark for FloShield™ 2
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
... ECTRA II systems permit the surgeon to ... endoscopically, allowing access via two portals for ... lens fogging with good air flow. ECTRA ... control. ECTRA knives permit the surgeon to ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Medicine Products: